Monvia officially commences trading on ASX today after completing its $17.5 million IPO

118 shareholders fall within the 10,000 to 100,000 share band, representing the largest single cohort in Monvia’s pre-listing holder distribution; additionally, there were zero registered holders in the 0–1,000 share range as of 20 July 2026.
ASIC extended the exposure period for the replacement prospectus from 7 to 14 days, with the offer open from 25 June 2026 and closing on 29 June 2026, indicating continued regulatory oversight during the IPO process.
A supplementary prospectus dated 8 July 2026 accompanied the replacement prospectus dated 24 June 2026, updating disclosures while noting that changes were not materially adverse to investors.
Trading of Monvia on the ASX commenced at 12:00pm AEST on 24 July 2026, with the listed code MNV and the trade abbreviation MONVIALTD.
Australian technology company Monvia Limited began trading on the ASX on 24 July 2026 under the ticker MNV, after completing a $17.5 million IPO priced at $1.10 per share, according to Kalkine Media. Trading kicked off at 12:00pm AEST, with the company listed under the trade abbreviation MONVIALTD.
The raise involved 15,909,090 ordinary shares and was fully underwritten by joint lead managers Euroz Hartleys and Unified Capital Partners, Kalkine reported. Monvia used most of the funds — about $12.5 million — to redeem its Series B Preference Shares, simplifying its capital structure ahead of listing.
The biggest use of IPO funds was redeeming Series B Preference Shares at around $12.5 million. This happened on the day of ASX admission, according to Kalkine Media. Preference shares are a special class of shares that rank above ordinary shares. Redeeming them removes that complexity and leaves investors with a cleaner, simpler structure.
The remaining capital is earmarked for growth, efficiency improvements, and research and development, Kalkine noted. The company has also set up formal governance ahead of listing, including a Board Charter and a Remuneration and Nomination Committee — standard steps for meeting ASX regulatory standards.
Monvia disclosed 295 registered shareholders across five holding bands ahead of its ASX listing, Kalkine reported. The largest single group — 118 shareholders — held between 10,000 and 100,000 shares. There were zero registered holders in the 0–1,000 share range as of 20 July 2026.
The company flagged that custodian arrangements can hide the true number of owners. In one case, a single registered shareholder for one broker actually represented about 32 underlying holders. This means the real investor base is likely larger than the headline figure of 295.
The path to listing included extra regulatory scrutiny. ASIC extended the exposure period for Monvia's replacement prospectus from 7 to 14 days. The offer opened on 25 June 2026 and closed on 29 June 2026, with the replacement prospectus dated 24 June 2026, according to Kalkine Media.
A supplementary prospectus followed on 8 July 2026. It updated disclosures but noted the changes were not materially adverse to investors. Monvia was admitted to the ASX on 22 July 2026 before trading began two days later on 24 July 2026, Market Screener confirmed.
The IPO raised exactly AUD 17,499,999 — effectively $17.5 million — through the sale of 15,909,090 shares at $1.10 each, according to Market Screener. The offer was fully underwritten, meaning the joint lead managers guaranteed the full amount would be raised regardless of public demand.
Euroz Hartleys and Unified Capital Partners served as joint lead managers for the raise, Kalkine reported. The completion of the prospectus process and underwriting marked the final steps before Monvia's shares began trading on the ASX under the code MNV.
Publishers
12
Articles
8
Reach
20